Poly (ADP-ribose) polymerase and DNA-dependent protein kinase: Differential activation in vivo

被引:0
作者
Narang, H [1 ]
Krishna, M [1 ]
Verma, NC [1 ]
机构
[1] Bhabha Atom Res Ctr, Radiat Biol & Hlth Sci Div, Radioprotect & Decontaminat Sect, Bombay 400085, Maharashtra, India
关键词
DNA; protein kinase; poly(ADP-ribose)polymerase; nuclear enzymes; radiation;
D O I
10.1615/JEnvPathToxOncol.v23.i1.40
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
DNA damage-activated homodimer of PARP-1 binds to single-strand breaks and catalyzes the synthesis and transfer of negatively charged ADP-ribose polymers to nuclear protein acceptors, including itself. It also undergoes site-specific proteolysis during apoptosis. On the other hand, DNA-PK is a heterotrimeric enzyme that specifically binds to double-strand breaks and phosphorylates its target proteins. Because both DNA breaks and apoptosis are known to occur following irradiation, whole-body irradiation was administered to find out the temporal pattern and dose-response of PARP expression and the activity pattern of DNA-PK. To assess the temporal response, male Wistar rats were subjected to a radiation dose of 3Gy and killed at various time intervals (1-24 hours). Both the PARP activity and expression were enhanced 4 hours after irradiation. Fragmented PARP was not observed until 24 hours after irradiation. The differential expression at DNA-PK various doses (0.1-5.0 Gy) was examined. The maximum expression of PARP was noted at 1 Gy, whereas the activation of DNA-PK was maximally observed at 3 Gy. We did not observe any increase in the expression of PARP until the dose of 3Gy was reached, which contradicted the findings in previous in vitro reports of PARP activation at high radiation doses. DNA-PK, however, showed a dose-dependent increase. Our results indicate that although both the PARP and the DNA-PK are nuclear enzymes with similar roles, the activation of these enzymes is dependent on the dose, and any extrapolation of data from in vitro observations can lead to misinterpretation.
引用
收藏
页码:45 / 51
页数:7
相关论文
共 50 条
  • [21] Replication protein A as a modulator of the poly(ADP-ribose)polymerase 1 activity
    Maltseva, Ekaterina A.
    Krasikova, Yulia S.
    Sukhanova, Maria V.
    Rechkunova, Nadejda I.
    Lavrik, Olga I.
    DNA REPAIR, 2018, 72 : 28 - 38
  • [22] PHOSPHORYLATION OF POLY(ADP-RIBOSE)POLYMERASE PROTEIN IN HUMAN PERIPHERAL LYMPHOCYTES STIMULATED WITH PHYTOHEMAGGLUTININ
    BAUER, PI
    FARKAS, G
    MIHALIK, R
    KOPPER, L
    KUN, E
    FARAGO, A
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1994, 1223 (02): : 234 - 239
  • [23] Role of the activation of the nuclear enzyme poly(ADP-ribose) polymerase in the pathogenesis of periodontitis
    Lohinai, Z
    Mabley, JG
    Fehér, E
    Marton, A
    Komjáti, K
    Szabó, C
    JOURNAL OF DENTAL RESEARCH, 2003, 82 (12) : 987 - 992
  • [24] A role of poly (ADP-ribose) polymerase in NF-κB transcriptional activation
    Hassa, PO
    Hottiger, MO
    BIOLOGICAL CHEMISTRY, 1999, 380 (7-8) : 953 - 959
  • [25] Endothelial dysfunction in aging animals:: the role of poly(ADP-ribose) polymerase activation
    Pacher, P
    Mabley, JG
    Soriano, FG
    Liaudet, L
    Komjáti, K
    Szabó, C
    BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135 (06) : 1347 - 1350
  • [26] INACTIVATION OF POLY(ADP-RIBOSE) POLYMERASE BY HYPOCHLOROUS ACID
    VANRENSBURG, CEJ
    VANSTADEN, AM
    ANDERSON, R
    FREE RADICAL BIOLOGY AND MEDICINE, 1991, 11 (03) : 285 - 291
  • [27] STRUCTURAL REQUIREMENTS FOR INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE
    SESTILI, P
    SPADONI, G
    BALSAMINI, C
    SCOVASSI, I
    CATTABENI, F
    DURANTI, E
    CANTONI, O
    HIGGINS, D
    THOMSON, C
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1990, 116 (06) : 615 - 622
  • [28] Cardioprotective effects of poly (ADP-ribose) polymerase inhibition
    Szabó, C
    PHARMACOLOGICAL RESEARCH, 2005, 52 (01) : 34 - 43
  • [29] Poly (ADP-ribose) Polymerase Inhibitors in Cancer Treatment
    Mason, Kathryn A.
    Raju, Uma
    Buchholz, Thomas A.
    Wang, Li
    Milas, Zvonimir L.
    Milas, Luka
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2014, 37 (01): : 90 - 100
  • [30] Poly(ADP-ribose)polymerase inhibition - Where now?
    Woon, ECY
    Threadgill, MD
    CURRENT MEDICINAL CHEMISTRY, 2005, 12 (20) : 2373 - 2392